Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2021

Feb 24, 2021

32853_dirs_2021-02-23_dd88ef10-4e6b-4242-83a0-5ecfa7af182a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2021-02-20

Reporting Person: Clague Laura (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-20 Common Stock A 9803 Acquired 37159 Direct

Footnotes

F1: Represents Restricted Stock Units that vest in four equal quarterly installments beginning on March 15, 2021. The Reporting Person has deferred settlement of the Restricted Stock Units until the earlier to occur of the Reporting Person's termination of service and a change of control.

F2: Represents Restricted Stock Units with respect to which the Reporting Person has deferred settlement as described above.